Endothelin. Pathways of transmembrane signaling.
Endothelin. Pathways of transmembrane signaling.
复制标题
内皮素。
DOI:
10.1161/01.hyp.15.2_suppl.i5
复制
发表时间:
1990
期刊:
影响因子:
--
通讯作者:
Dunn,MJ
中科院分区:
文献类型:
--
作者:
Simonson,MS;Dunn,MJ
The endothelium synthesizes and releases paracrine hormones that regulate the contraction and physiology of vascular smooth muscle cells. 1-3 In addition to the well-described vasorelaxant factors (ie, endothelial-derived relaxing factor [EDRF] and prostaglandin [PG] I2), experimental evidence has suggested that the endothelium also releases vasoconstrictor compounds. 4-6 Yanagisawa and coworkers7 recently purified and sequenced endothelin (ET), a potent vasoconstrictor peptide synthesized by endothelial cells and other tissues in vitro and in vivo. The discovery of ET has generated tremendous interest, not only because it seems to be the most potent vasoconstrictor substance yet identified but because of its potential involvement in disease. 8 The purpose of this brief review is to describe recent advances that have elucidated mechanisms of transmembrane signaling after ET-receptor interactions. Using glomerular mesangjal cells as a model, we will focus on 1) the multiple mechanisms by which ET elevates intracellular free [Ca2+], 2) activation of phospholipase C to produce inositol phosphate second messengers, and 3) stimulation of phospholipase A2 by ET to form arachidonate-derived, negative feedback signals.